Your browser doesn't support javascript.
loading
Multicomponent antibiotic substances produced by fermentation: implications for regulatory authorities, critically ill patients and generics.
Brink, Adrian J; Richards, Guy A; Colombo, Gaia; Bortolotti, Fabrizio; Colombo, Paolo; Jehl, François.
Affiliation
  • Brink AJ; Department of Clinical Microbiology, Ampath National Laboratory Services, Suite 9C, Milpark Hospital, 9 Guild Road, Parktown West, 2193 Johannesburg, South Africa. Electronic address: brinka@ampath.co.za.
  • Richards GA; Department of Critical Care, Charlotte Maxeke Johannesburg Academic Hospital and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Colombo G; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
  • Bortolotti F; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
  • Colombo P; Department of Pharmacy, University of Parma, Parma, Italy.
  • Jehl F; Bacteriology Laboratory, Faculty of Medicine, University Hospital Strasbourg, Strasbourg, France.
Int J Antimicrob Agents ; 43(1): 1-6, 2014 Jan.
Article in En | MEDLINE | ID: mdl-23920094
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Teicoplanin / Colistin / Anti-Bacterial Agents Limits: Humans Language: En Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Teicoplanin / Colistin / Anti-Bacterial Agents Limits: Humans Language: En Year: 2014 Type: Article